Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Real-World Experience Using Letermovir for CMV Prophylaxis in High-Risk Allogeneic Hematopoietic Stem Cell Patients in the Setting of Using T-Cell Depletion As Gvhd Prophylaxis and the Impact on CMV Reactivation, 1-Year Overall Survival, and 1-Year Gvhd-Free-Relapse-Free Survival

Sami Dwabe, MD, Mindy Hsiao, MD, George Yaghmour, MD

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-143309

Published: 2020

Journal Articles

Evaluating Gvhd Outcomes Using Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil As Gvhd Prophylaxis Compared with Methotrexate/Tacrolimus in Matched-Related and Matched-Unrelated Hematopoietic Stem Cell Transplant in Relation to the Haplo-Identical Setting: A Single Center Experience

Mindy Hsiao, MD, Preet M. Chaudhary, MD PhD, George Yaghmour, MD

Blood (2020) 136 (Supplement 1): 6.

https://doi.org/10.1182/blood-2020-141659

Published: 2020

Journal Articles

Investigating the Relationship between CD34 + and CD3 + Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation: A Single Center Experience

Mindy Hsiao, MD, Anastasia Martynova, MD, George Yaghmour, MD, Chris Foss, MD

Blood (2019) 134 (Supplement_1): 2051.

https://doi.org/10.1182/blood-2019-129647

Published: 2019

Journal Articles

A Comparison between BEAM and BEM Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Relapsed Lymphoma: A Descriptive Analysis

Kevin Yen, BS, Lan Y Wang, MD, Mindy Hsiao, MD, Kum Ja Lee, PharmD, Mojtaba Akhtari, MD

Blood (2018) 132 (Supplement 1): 5761.

https://doi.org/10.1182/blood-2018-99-120221

Published: 2018

Journal Articles

Investigating the Relationship between Graft-Versus-Host Disease Incidence and Increased Risk of Death within Three Years after Allogeneic Hematopoietic Stem Cell Transplantation in Patients Receiving Antibiotics Containing Activity Against Obligate Anaerobes

Mojtaba Akhtari, MD, Mindy Hsiao, MD

Blood (2017) 130 (Supplement 1): 4507.

https://doi.org/10.1182/blood.V130.Suppl_1.4507.4507

Published: 2017

NARROW

Real-World Experience Using Letermovir for CMV Prophylaxis in High-Risk Allogeneic Hematopoietic Stem Cell Patients in the Setting of Using T-Cell Depletion As Gvhd Prophylaxis and the Impact on CMV Reactivation, 1-Year Overall Survival, and 1-Year Gvhd-Free-Relapse-Free Survival

Investigating the Relationship between CD34 + and CD3 + Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation: A Single Center Experience

A Comparison between BEAM and BEM Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Relapsed Lymphoma: A Descriptive Analysis

Investigating the Relationship between Graft-Versus-Host Disease Incidence and Increased Risk of Death within Three Years after Allogeneic Hematopoietic Stem Cell Transplantation in Patients Receiving Antibiotics Containing Activity Against Obligate Anaerobes

Email alerts

ASH Publications

American Society of Hematology

Real-World Experience Using Letermovir for CMV Prophylaxis in High-Risk Allogeneic Hematopoietic Stem Cell Patients in the Setting of Using T-Cell Depletion As Gvhd Prophylaxis and the Impact on CMV Reactivation, 1-Year Overall Survival, and 1-Year Gvhd-Free-Relapse-Free Survival

Investigating the Relationship between CD34 + and CD3 + Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation: A Single Center Experience

A Comparison between BEAM and BEM Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Relapsed Lymphoma: A Descriptive Analysis

Investigating the Relationship between Graft-Versus-Host Disease Incidence and Increased Risk of Death within Three Years after Allogeneic Hematopoietic Stem Cell Transplantation in Patients Receiving Antibiotics Containing Activity Against Obligate Anaerobes

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only